Centessa Reverses Lower Despite $5 Billion Narcolepsy Opportunity
Investor's Business DailyCentessa has a potential blockbuster narcolepsy treatment on its hands, an analyst said Tuesday. But the biotech stock reversed into the red.
The post Centessa Reverses Lower Despite $5 Billion Narcolepsy Opportunity appeared first on Investor's B…